Stockreport

CytRx Notes Topline Data From Trial of Arimoclomol in Amyotrophic Lateral Sclerosis

Orphazyme A/S - American Depositary Shares  (ORPH) 
PDF LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (OTCQB: CYTR) ("CytRx"), a specialized biopharmaceutical company focused on research and development for the oncology [Read more]